Status
Conditions
Treatments
About
To evaluate the overall safety and tolerability profile of two dose levels of DVS-233 SR during 6 months of open-label treatment in elderly outpatients with major depressive disorder.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Other exclusion applies.
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal